The global markets are increasingly dynamic and are undergoing major changes and upheavals. The increasing demand of the pharma industry for highly sensitive drugs such as biologics and biosimilars predominantly require an ever-higher cleanliness in production such as cleanroom manufacturing – especially with a view on the existing regulatory framework. The automotive industry is switching to sustainable mobility concepts and is looking for sophisticated, environmentally friendly technologies. For well-positioned companies such as Datwyler, these changes offer attractive opportunities. In 2018, we have again undertaken many efforts to meet the challenges in the markets while accelerating profitable growth and leveraging on our innovation potential.